Get the Stockscreener App
1.84
41.59%
-1.31
After Hours:
1.94
0.10
+5.43%
Pulmonx Corp stock is traded at $1.84, with a volume of 4.63M.
It is down -41.59% in the last 24 hours and down -28.96% over the past month.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
See More
Previous Close:
$3.15
Open:
$1.99
24h Volume:
4.63M
Relative Volume:
10.24
Market Cap:
$74.07M
Revenue:
$68.68M
Net Income/Loss:
$-60.84M
P/E Ratio:
-1.15
EPS:
-1.6
Net Cash Flow:
$-38.42M
1W Performance:
-44.49%
1M Performance:
-28.96%
6M Performance:
-67.61%
1Y Performance:
-73.37%
1-Day Range:
$1.75
$2.03
1-Week Range:
$1.75
$3.4053
52-Week Range:
$1.75
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Name
Pulmonx Corp
Sector
Industry
Phone
650-364-0400
Address
700 CHESAPEAKE DRIVE, REDWOOD CITY
Compare LUNG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.84 | 126.81M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-25 | Initiated | D. Boral Capital | Buy |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-04-24 | Initiated | Lake Street | Buy |
| Feb-23-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-05-23 | Initiated | Craig Hallum | Buy |
| Feb-27-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Mar-25-21 | Initiated | Piper Sandler | Neutral |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-20 | Initiated | BofA Securities | Buy |
| Oct-26-20 | Initiated | Canaccord Genuity | Buy |
| Oct-26-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-26-20 | Initiated | Stifel | Buy |
| Oct-26-20 | Initiated | Wells Fargo | Equal Weight |
View All
Pulmonx Corp Stock (LUNG) Latest News
Pulmonx Corp (LUNG) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings - Benzinga
Will GRDN price bounce be sustainableStrong Buy Opportunity with Volume Support - Newser
Should I buy Riverview Bancorp Inc. stock before earningsReal-Time AI Sentiment and Price Forecast - Newser
Pulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges - Yahoo.co
Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns By Investing.com - Investing.com South Africa
What to expect from Pulmonx Corporation in the next 30 daysSwing Gain Strategy with Entry Forecast - Newser
CNB Financial Corporation stock retracement – recovery analysisPortfolio Risk Distribution Analysis Tool - Newser
Is Canada Goose Holdings Inc. showing signs of accumulationWeekly Return Plan for Conservative Traders - Newser
Tools to monitor Pulmonx Corporation recovery probabilityFree Real-Time Analysis With Entry Targets - Newser
Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains - Investing.com Canada
Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains By Investing.com - Investing.com South Africa
Pulmonx Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Pulmonx earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Option Care Health Inc. Building a Base Near SupportBreakout Confirmation With Entry Tracker Enabled - metal.it
Can trapped investors hope for a rebound in Sally Beauty Holdings Inc.Intraday Price Forecast Using Volume Models - Newser
What the charts say about Pulmonx Corporation todayLoss Limitation Strategy Based on Analysis - Newser
Is Delek US Holdings Inc. stock ready for a breakoutVolume Confirmed Setup with Entry Confidence - Newser
Leading Lung Disease Treatment Company Pulmonx Showcases Growth Story at Major Healthcare Conference - Stock Titan
Why SL Green Realty Corp. stock is on top investor watchlistsSector Rotation and Stock Opportunity Analysis - Newser
Price Channel Expanding on Pulmonx Corporation’s ChartCapital Preserving Trade Plan Templates Shared - metal.it
Pulmonx Corporation Stock Support and Resistance Levels You Should KnowWeekly Double Return List - metal.it
What makes HFBL stock price move sharplyInsider Strategy Insight - Newser
How Pulmonx Corporation stock performs during market volatilityWeekly Stock Picks with Trend Confidence - Newser
What analysts say about Pulmonx Corporation stockExceptional growth trajectory - jammulinksnews.com
Is Pulmonx Corporation a good long term investmentUnprecedented growth rates - jammulinksnews.com
What drives Pulmonx Corporation stock priceSuperior return velocity - jammulinksnews.com
Can Spring Valley Acquisition Corp. II Equity Right stock recover from recent declineDaily Breakout Picks - Newser
Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 - The Manila Times
Pulmonx Sets Q2 Earnings Date: Leading Lung Disease Treatment Maker to Update Investors July 30 - Stock Titan
Why Pulmonx Corporation stock attracts strong analyst attentionChart Based Entries - Newser
What makes Pulmonx Corporation stock price move sharplyBreakout Confirmation Tool - Newser
Vontobel Holding Ltd. Buys Shares of 12,116 Pulmonx Corporation (NASDAQ:LUNG) - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
EOG Resources, Inc (EOG) Stock: A Year of Declines and Increases - investchronicle.com
Insider Sell: Richard Ferrari Sells 8,000 Shares of Pulmonx Corp (LUNG) - GuruFocus
Bank of America Corp DE Grows Stock Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx at Goldman Sachs Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Pulmonx at Goldman Sachs Conference: Strategic Growth Insights - Investing.com Australia
Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Pulmonx director Florin Daniel P buys $71,362 in common stock By Investing.com - Investing.com Nigeria
Insider Buying: Daniel Florin Acquires Shares of Pulmonx Corp (L - GuruFocus
Pulmonx director Florin Daniel P buys $71,362 in common stock - Investing.com
Pulmonx Co. (NASDAQ:LUNG) Stock Holdings Lifted by Millennium Management LLC - Defense World
Pulmonx Corp Executives Sell Shares to Cover Tax Obligations - TradingView
Northern Trust Corp Increases Position in Sonder Holdings Inc. (NASDAQ:SOND) - Defense World
Northern Trust Corp Raises Holdings in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World
Bank of America Corp DE Sells 4,036 Shares of SPDR S&P Telecom ETF (NYSEARCA:XTL) - Defense World
Northern Trust Corp Acquires New Shares in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Defense World
Northern Trust Corp Makes New Investment in BlackRock MuniHoldings Fund, Inc. (NYSE:MHD) - Defense World
Pulmonx Corp Stock (LUNG) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):